ThomasM.LietmanMD

Ophthalmology • San Francisco, CA

Professor and Director, Francis I Proctor Foundation, UCSF School of Medicine

Join to view full profile

Dr. Lietman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lietman's full profile

Already have an account?

Office
95 Kirkham St
F.I. Proctor Foundation
San Francisco, CA 94143
Phone+1 415-476-1442

Fax+1 415-476-0527

Education & Training

Johns Hopkins UniversityResidency, Ophthalmology, 1991 - 1994
MedStar Health Georgetown University (Baltimore)Internship, Internal Medicine, 1990 - 1991
Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Yale CollegeBA, 1980 - 1984

Certifications & Licensure

CA State Medical License 1994 - 2026
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Trachoma Elimination Follow-up Start of enrollment: 2003 Mar 01
Completed
Phase 4
Steroids for Corneal Ulcers Trial Start of enrollment: 2006 Sep 01
Completed
Phase 4
Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Start of enrollment: 2007 Nov 01
Completed
Phase 1, Phase 2
Mortality Reduction After Oral Azithromycin: Mortality Study Start of enrollment: 2014 Dec 01
Completed
Phase 4
Infant Mortality Reduction by the Mass Administration of Azithromycin Start of enrollment: 2021 Oct 04
ACTIVE_NOT_RECRUITING
PHASE4
Roles: Principal Investigator
Steroids and Cross-linking for Ulcer Treatment Start of enrollment: 2020 Sep 24
COMPLETED
PHASE3
Roles: Sponsor-Investigator
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction Start of enrollment: 2022 Aug 03
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Sponsor-Investigator
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II Start of enrollment: 2024 Jul 01
RECRUITING
PHASE3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Seasonality of underweight among infants 1-11 months old in Niger: an exploratory analysis of data from a cluster-randomised trial.
Brittany Peterson, Ahmed Mamane Arzika, Ramatou Maliki, Amza Abdou, Bawa Aichatou
BMJ Global Health. 2025-03-28
Mass distribution of azithromycin and child mortality among underweight infants in rural Niger: a subgroup analysis of the AVENIR cluster-randomised trial.
Brittany Peterson, Ahmed Arzika, Ramatou Maliki, Amza Abdou, Bawa Aichatou
BMJ Open. 2025-03-27
Association of Weather Variables With Pathogens Contributing to Conjunctivitis Worldwide.
Daisy Yan, N Venkatesh Prajna, Prajna Lalitha, Wiwan Sansanayudh, Vannarut Satitpitakul
Clinical Infectious Diseases. 2025-03-17

Journal Articles

Mass Azithromycin Distribution for Hyperendemic Trachoma Following a Cluster-Randomized Trial: A Continuation Study of Randomly Reassigned Subclusters (TANA II)
Jeremy D Keenan, Thomas M Lietman, PLoS One
F Effect of Antibiotics on Short-Term Growth Among Children in Burkina Faso: A Randomized Trial
Thomas M Lietman, Jeremy D Keenan, The American Journal of Tropical Medicine and Hygiene
Anthropometry and Malaria Among Children in Niger: A Cross-Sectional Study
Thomas M Lietman, Bruce D Gaynor, The American Journal of Tropical Medicine and Hygiene
School-Based Versus Community-Based Sampling for Trachoma Surveillance
Thomas M Lietman, Jeremy D Keenan, The American Journal of Tropical Medicine and Hygiene
The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-Randomized Trial
Jeremy D Keenan, Thomas M Lietman, Clinical Infectious Diseases
Join now to see all

Press Mentions

Giving an Antibiotic to All Children Under 5 in Africa Saves LivesAugust 21st, 2024
Common Antibiotic No More Effective Than Placebo in Preventing COVID-19 Symptoms Among Non-Hospitalized: Outpatient Study Found Limited Effect of Azithromycin on Progression of DiseaseJuly 18th, 2021
Study Suggests Mass Azithromycin May Promote Resistance to Other AntibioticsNovember 13th, 2020
Join now to see all

Grant Support

Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
Forecasting Trachoma ControlUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2016–2028
Forecasting Trachoma ControlUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2016–2028
Forecasting Trachoma ControlUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2016–2028
Azithromycin Reduction to Reach Elimination of TrachomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
UCSF-Proctor Clinician Vision Scholars K12 ProgramUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
Steroids and Cross-linking for Ulcer Treatment (SCUT II)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025
Kebele Elimination of Trachoma for Ocular HealthUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2017–2025
Tana IINational Eye Institute2010–2011
Myocotic Ulcer Treatment TrialNational Eye Institute2009–2011
The Steroids For Cornea Ulcers TrialNational Eye Institute2005–2009
Eliminating Trachoma With Repeat Mass Drug TreatmentNational Eye Institute2004–2009
Predicting Resistance: Validating Mathematical ModelsNational Institute Of Allergy And Infectious Diseases2003–2004
Transmission Dynamics Of TrachomaNational Institute Of Allergy And Infectious Diseases1997–2001